Florida executes prisoner with etomidate despite drug maker’s concerns
BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j4057 (Published 30 August 2017) Cite this as: BMJ 2017;358:j4057- Owen Dyer
Florida has used the anesthetic etomidate for the first time in a US execution, opening a new front in the running battle between states that wish to lethally inject inmates and a drug industry determined to stop executioners from using its products.
Mark Asay, who was convicted of two racially motivated murders in 1987, was pronounced dead 22 minutes after his scheduled execution time. He chose not to make a final statement, and witnesses saw no evidence of complications or suffering.
The execution was unique in three ways. Asay was the first white man in Florida history to be executed for killing a black man. He was …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.